Study to Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Participants With Staphylococcus Aureus Bacteremia Receiving Standard-of-Care (SOC) Antibiotics
Clinical trial NCT03162250 · COMPLETED
Trial details
- NCT number
- NCT03162250
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-13
- Primary completion
- 2020-01-15
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.